ADAM17

ADAM17 詳細

英語名Disintegrin and metalloproteinase domain-containing protein 17市販薬剤の数0
治験薬の数2ターゲットの別称EC:3.4.24.86,ADAM17 Protein,ADAM 17,Snake venom-like protease,CSVP,CD156b,ADAM17,ADAM Metallopeptidase Domain 17,TNF-Alpha Convertase,TACE,TNF-Alpha Converting Enzyme,TNF-Alpha-Converting Enzyme,CD156b Antigen,EC 3.4.24.86,NISBD1,NISBD,Disintegrin and metalloproteinase domain-containing protein 17,Tumor Necrosis Factor, Alpha, Converting Enzyme,ADAM Metallopeptidase Domain 18,ADAM18
研究&開発段階Phase 1 Clinical
英語名Disintegrin and metalloproteinase domain-containing protein 17
ターゲットの別称EC:3.4.24.86,ADAM17 Protein,ADAM 17,Snake venom-like protease,CSVP,CD156b,ADAM17,ADAM Metallopeptidase Domain 17,TNF-Alpha Convertase,TACE,TNF-Alpha Converting Enzyme,TNF-Alpha-Converting Enzyme,CD156b Antigen,EC 3.4.24.86,NISBD1,NISBD,Disintegrin and metalloproteinase domain-containing protein 17,Tumor Necrosis Factor, Alpha, Converting Enzyme,ADAM Metallopeptidase Domain 18,ADAM18
市販薬剤の数0
治験薬の数2
研究&開発段階Phase 1 Clinical

ADAM17 製品リスト

  • 属性

    Protein (2)

  • 製品ライブラリ

    オンライン (2)

  • 種

    Mouse (1)Human (1)

  • タグ

    His Tag (2)

  • マーカー

    Unconjugated (2)

製品番号種発現システム製品説明タンパク質の構造純度特性
Human
CHO
Human ADAM17 / TACE / CD156b Protein, His Tag (active enzyme)
Mouse
HEK293
Mouse ADAM17 / TACE / CD156b Protein, His Tag
総数量2
  • 1

ADAM17バックグランド

Disintegrin and metalloproteinase domain-containing protein 17 (ADAM17), a member of the ADAM protein family of disintegrins and metalloproteases, is also known as TNF-alpha convertase, TNF-alpha-converting enzyme and CD156b, which contains one disintegrin domain and one peptidase M12B domain. ADAM17 can cleave the membrane-bound precursor of TNF-alpha to its mature soluble form. ADAM17 is also responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (By similarity) and proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein. Furthermore, ADAM17 acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation.

ADAM17分子の別称

ADAM17,TACE,CD156b

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AderbasibINCB-7839; INC-B007839; INCB-007839Phase 1 ClinicalIncyte CorpAstrocytoma; Breast Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Oligodendroglioma; Solid tumours
詳細
ORYN-1001ORTD-1; ORYN-1001Phase 1 ClinicalOryn Therapeutics LlcArthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報